Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.48 USD | +2.05% | +3.74% | -37.72% |
04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.72% | 574M | |
+19.28% | 84.52B | |
-26.95% | 72.21B | |
+4.65% | 27.74B | |
-7.35% | 17.97B | |
-0.46% | 17.46B | |
+4.69% | 15.82B | |
+8.14% | 13.55B | |
+6.59% | 13.31B | |
+70.00% | 12.5B |
- Stock Market
- Equities
- ACCD Stock
- News Accolade, Inc.
- Accolade Fiscal Q1 Loss Narrows as Revenue Rises; Lifts Fiscal 2024 Revenue Guidance; Shares Surge Premarket